← News
Aug 20, 2026 Psychedelics
New on Altitude: Who Actually Holds Psilocybin's 223 Patents
Psilocybin leads every compound in our patent tracker on combined activity, and four holders — COMPASS Pathways, Enveric Biosciences, Turtle Bear Holdings, and CaaMTech — account for most of the granted patents between them. We dug into what each is actually claiming, why one nonprofit running an FDA-vouchered trial holds zero patents on purpose, and how Compass survived a million-dollar legal challenge to keep its patents alive. Read the full breakdown here.
Read at Altitude